KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Current Deferred Revenue: 2012-2014

Historic Current Deferred Revenue for TherapeuticsMD (TXMD) over the last 1 years, with Dec 2014 value amounting to $522,613.

  • TherapeuticsMD's Current Deferred Revenue fell 67.39% to $522,613 in Q4 2014 from the same period last year, while for Dec 2014 it was $522,613, marking a year-over-year decrease of 67.39%. This contributed to the annual value of $522,613 for FY2014, which is 67.39% down from last year.
  • As of Q4 2014, TherapeuticsMD's Current Deferred Revenue stood at $522,613, which was down 67.39% from $1.6 million recorded in Q4 2013.
  • In the past 5 years, TherapeuticsMD's Current Deferred Revenue registered a high of $1.6 million during Q4 2013, and its lowest value of $522,613 during Q4 2014.
  • Moreover, its 3-year median value for Current Deferred Revenue was $922,151 (2012), whereas its average is $955,521.
  • Per our database at Business Quant, TherapeuticsMD's Current Deferred Revenue surged by 39.99% in 2013 and then crashed by 67.39% in 2014.
  • Over the past 3 years, TherapeuticsMD's Current Deferred Revenue (Quarterly) stood at $1.1 million in 2012, then skyrocketed by 39.99% to $1.6 million in 2013, then crashed by 67.39% to $522,613 in 2014.
  • Its last three reported values are $522,613 in Q4 2014, $1.6 million for Q4 2013, and $1.1 million during Q1 2013.